{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:45:31Z","timestamp":1790372731431,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gaucher disease is a rare lysosomal storage disorder caused by insufficient activity of the enzyme \u03b2-glucocerebrosidase. This leads to the accumulation of fatty deposits in cells and tissues and damages multiple organ systems. Diagnosing Gaucher disease often involves a prolonged and challenging \u201cdiagnostic odyssey\u201d. The International Gaucher Alliance (IGA) conducted a survey among individuals living with Gaucher disease, including patients, families, and caregivers, to investigate diagnostic challenges. Distributed primarily in English language, with a Spanish translation for relevant IGA members, the survey was completed by 142 respondents from 40 different countries between November 2024 and February 2025. The study aims to guide future efforts to promote timely diagnosis, access to expert management, and treatment before irreversible damage occurs. Early diagnosis also brings emotional and practical benefits, including informed family planning and support networks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The survey revealed that diagnostic delays remain prevalent, with 58% of respondents waiting more than a year for diagnosis. Key contributors to delays included low awareness among physicians and inadequate communication between medical specialties. Common \u201cred flag\u201d symptoms identified in guidelines were often linked to eventual diagnosis, highlighting the need to educate healthcare professionals, especially those likely to encounter patients but not consider Gaucher disease (e.g., internal medicine specialists and gastroenterologists). Notably, 17% of respondents were not made aware of the genetic nature of Gaucher disease when they were diagnosed, potentially missing opportunities to identify affected relatives or influence family planning. Respondents suggested that increased awareness among healthcare professionals, expanded access to newborn screening, and greater availability of genetic and enzymatic testing could significantly accelerate the process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>As well as continuing to engage in education and awareness activities for specialists that commonly diagnose Gaucher, targeted awareness campaigns for secondary care clinicians that do not commonly diagnose Gaucher, but are regularly seen in the journey to diagnosis could reduce diagnostic delays. Providing lay-friendly resources to help specialists explain genetic inheritance to newly diagnosed patients may enhance early family diagnoses. Country-specific surveys to understand local diagnostic experiences could shape tailored interventions. Lastly, advocacy efforts to address access barriers, should amplify patient voices and prioritise community needs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04209-5","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:35:08Z","timestamp":1771616108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring delayed diagnosis in Gaucher disease: insights from a community survey and potential solutions"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4758-7805","authenticated-orcid":false,"given":"Diana Paulina Pe\u00f1a","family":"Arag\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Collin-Histed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magy","family":"Abdelwahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Villarrubia","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Chertkoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Balzekiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Pacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"1","key":"4209_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2022.03.001","volume":"136","author":"N Weinreb","year":"2022","unstructured":"Weinreb N, Goker-Alpan O, Kishnani P, et al. The diagnosis and management of Gaucher disease in pediatric patients: where do we go from here? Mol Genet Metab. 2022;136(1):4\u201321.","journal-title":"Mol Genet Metab"},{"issue":"24","key":"4209_CR2","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.3390\/diagnostics14242840","volume":"14","author":"D M\u00e9ndez-Cobi\u00e1n","year":"2024","unstructured":"M\u00e9ndez-Cobi\u00e1n D, Guzm\u00e1n-Silahua S, Garc\u00eda-Hern\u00e1ndez D, et al. An overview of Gaucher disease. Diagnostics (Basel). 2024;14(24):2840.","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"4209_CR3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/imj.14156","volume":"49","author":"A Mehta","year":"2019","unstructured":"Mehta A, Kuter D, Salek S, et al. Presenting signs and patient co-variables in Gaucher disease: outcome of the gaucher earlier diagnosis consensus (GED-C) Delphi initiative. Intern Med J. 2019;49(5):578\u201391.","journal-title":"Intern Med J"},{"key":"4209_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/TCRM.S388266","volume":"21","author":"S Nishimura","year":"2025","unstructured":"Nishimura S, Ma C, Sidransky E, et al. Obstacles to early diagnosis of Gaucher disease. Ther Clin Risk Manag. 2025;21:93\u2013101.","journal-title":"Ther Clin Risk Manag"},{"key":"4209_CR5","doi-asserted-by":"crossref","unstructured":"Mistry P, Cappellini M, Lukina E, et al. Consensus conference: a reappraisal of Gaucher disease - diagnosis and disease management algorithms. Am J Hematol. 201;86(1):110\u20135.","DOI":"10.1002\/ajh.21888"},{"key":"4209_CR6","unstructured":"Gaucher Disease - A 20 Year Diagnostic Journey. Rare Disease Report. Available at: https:\/\/youtu.be\/4SBChnEvKlY. Last accessed July 2025."},{"issue":"1","key":"4209_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13023-017-0627-z","volume":"12","author":"M Andrade-Campos","year":"2017","unstructured":"Andrade-Campos M, Alfonso P, Irun P, et al. Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish registry of Gaucher disease. Orphanet J Rare Dis. 2017;12(1):84.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4209_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13023-023-02868-2","volume":"18","author":"A Wilson","year":"2023","unstructured":"Wilson A, Chiorean A, Aguiar M, et al. Development of a rare disease algorithm to identify persons at risk of Gaucher disease using electronic health records in the united States. Orphanet J Rare Dis. 2023;18(1):280.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"4209_CR9","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.3390\/biomedicines11102672","volume":"11","author":"C Rossi","year":"2023","unstructured":"Rossi C, Ferrante R, Valentinuzzi S, et al. Noninvasive DBS-Based approaches to assist clinical diagnosis and treatment monitoring of Gaucher disease. Biomedicines. 2023;11(10):2672.","journal-title":"Biomedicines"},{"issue":"1","key":"4209_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13023-022-02573-6","volume":"17","author":"A Dardis","year":"2022","unstructured":"Dardis A, Michelakakis H, Rozenfeld P, et al. Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1. Orphanet J Rare Dis. 2022;17(1):442.","journal-title":"Orphanet J Rare Dis"},{"key":"4209_CR11","unstructured":"International Gaucher Alliance (IGA). Global Gaucher Connect Programme. Available at: https:\/\/gaucheralliance.org\/global-gaucher-connect-programme\/. Last accessed June 2025."},{"key":"4209_CR12","first-page":"9454506","volume":"2016","author":"L Boulet","year":"2016","unstructured":"Boulet L. The expert patient and chronic respiratory diseases. Can Respir J. 2016;2016:9454506.","journal-title":"Can Respir J"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04209-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04209-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04209-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:57:05Z","timestamp":1775127425000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04209-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4209"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04209-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are part of the IGA and support local initiatives in their respective countries to advance recognition, support and care for people affected by Gaucher disease. MA is a member of the IWGGD and participating on behalf of physicians.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}